TGFβ has been shown to suppress the antitumor activity of T cells, natural killer (NK) cells, neutrophils, monocytes, and macrophages, which together are able to promote or repress tumor progression depending on the cellular context [25–27]. The gene discussed is TGFB1; the disease is neoplasm.